When donald trump moved back into the White House, the United States was years into its Cancer Moonshot, a multibillion-dollar Democratic effort to halve cancer deaths by 2047. There was a kind of stalemate: New cases of the disease were emerging about as often as before; deaths were ticking steadily lower; the US Food and Drug Administration was approving new treatments, if not quite as quickly as anyone wanted. But the taps of federal funding were open as never before, from the Department of Defense to the Environmental Protection Agency to the largest funder of cancer research in the world, the National Institutes of Health.
But then Trump decided that